Success Metrics

Clinical Success Rate
100.0%

Based on 26 completed trials

Completion Rate
100%(26/26)
Active Trials
4(13%)
Results Posted
42%(11 trials)

Phase Distribution

Ph phase_1
13
43%
Ph phase_3
11
37%
Ph phase_4
1
3%
Ph phase_2
3
10%

Phase Distribution

13

Early Stage

3

Mid Stage

12

Late Stage

Phase Distribution28 total trials
Phase 1Safety & dosage
13(46.4%)
Phase 2Efficacy & side effects
3(10.7%)
Phase 3Large-scale testing
11(39.3%)
Phase 4Post-market surveillance
1(3.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

26 of 26 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

30

all time

Status Distribution
Active(4)
Completed(26)

Detailed Status

Completed26
Recruiting4

Development Timeline

Analytics

Development Status

Total Trials
30
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 113 (46.4%)
Phase 23 (10.7%)
Phase 311 (39.3%)
Phase 41 (3.6%)

Trials by Status

recruiting413%
completed2687%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT05823948Phase 3

A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

Completed
NCT05813912Phase 3

A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

Completed
NCT06807190

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

Recruiting
NCT05790681Phase 1

A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

Completed
NCT06340854Phase 3

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

Completed
NCT07076199Phase 3

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Recruiting
NCT07112339Phase 4

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Recruiting
NCT07160816

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

Recruiting
NCT04770532Phase 3

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin

Completed
NCT04460885Phase 3

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before

Completed
NCT04880850Phase 3

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

Completed
NCT05352815Phase 3

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

Completed
NCT04848480Phase 3

A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

Completed
NCT04760626Phase 3

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

Completed
NCT06288412Phase 1

A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

Completed
NCT05435677Phase 1

A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together

Completed
NCT03723772Phase 1

A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week

Completed
NCT04795531Phase 3

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Completed
NCT03723785Phase 1

A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems

Completed
NCT04597697Phase 1

A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease

Completed

Drug Details

Intervention Type
DRUG
Total Trials
30